Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
Recruiting · NCT05497024 · Observational (researchers observe without assigning treatment) · Lead sponsor: M.D. Anderson Cancer Center
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.
Who can take part
Inclusion criteria
- Males aged 65 or older
- Diagnosis of localized prostate cancer
- On active surveillance for 12 or more months
- Fluent in English
Exclusion criteria
- \. Receiving treatment for another cancer (primary or recurrence)
- Caregivers
- Inclusion Criteria:
- Aged 18 or older
- Fluent in English
- Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion)
- Exclusion Criteria:
- None
- Clinicians
- Inclusion Criteria:
- Aged 18 or older
- Fluent in English
- Provides clinical care for patients with prostate cancer (e.g. medical oncologists, urologists, radiation oncologists, nurse practitioners, physician assistants)
- Exclusion Criteria:
- \. None
Where it is running
1 location listed across 1 US state.
- M D Anderson Cancer Center - Houston, Texas, United States